MedTrace Logo

Long Term Effects of Treating Submassive Pulmonary Embolism With Ultra-sound Accelerated Thrombolysis

NCT01899339 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2023-07-18

No results posted yet for this study

Summary

Patients with Submassive Pulmonary Embolism treated with ultra-sound therapy will have an improved right ventricular function 72 hours post treatment.

Conditions

  • Submassive Pulmonary Embolism

Interventions

OTHER

submassive PA treatment with Ekosonic endo device

Ultra Sound energy along with tPA to treat submassive pulmonary embolism

Sponsors & Collaborators

  • EKOS Corporation

    collaborator INDUSTRY

  • Spectrum Health Hospitals

    lead OTHER

Principal Investigators

  • Michael Knox, MD · Spectrum Health Hosptials and ARS

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2019-02-28
Completion
2019-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01899339 on ClinicalTrials.gov